Report : Europe GMP Testing Service Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Service Type (Product Validation Testing, Bioanalytical Services, Packaging & Shelf Life Testing, and Other Services Type) and End User (Pharmaceutical and Biopharmaceutical Companies, and Medical Device Companies)
At 6.4% CAGR, the Europe GMP Testing Service Market is speculated to be worth US$ 897.22 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Europe GMP testing service market was valued at US$ 616.77 million in 2022 and is expected to reach US$ 897.22 million by 2028, registering a CAGR of 6.4% from 2022 to 2028. Continuous propagation of pharmaceuticals industry and flourishment of medical device manufacturing are the critical factors attributed to the Europe GMP testing service market expansion.
Research and development (R&D) fundamentally include two important phases of preproduction activity. The former revolves around a planned experiment to review, analyze, and revise the accepted or established principles and draw conclusions or rectify already known facts of knowledge if required; however, in the latter phase, the results of the former activities are checked in practical application scenarios to check their reproducibility in the production phase either by developing new or improved products. Although the performance of a product under investigation is often unknown or not optimized, compliance with the GMPs is critical to the safety and efficacy of investigational medicines. Notebook reviews, spot inspections, and varied training programs, among other methods, are used to ensure better compliance in analytical laboratories, wherein investigational medicines are tested before their release for clinical use. As electronic systems such as laboratory information management system (LIMS), electronic databases, and data acquisition software are an integral part of scientists’ work, they must be capable of proper utilization of these systems. Notebook documentation, analytical instrumentation logs (calibration records and cross-references), method execution, laboratory operations, and electronic records are pivotal to ensuring GMPs. The compliance of all key actions and documents is assessed against current expected departmental work practices, instrument operating procedures (IOPs), and standard operating procedures (SOPs), and the findings are captured on standard forms. Thus, R&D departments are focusing on the use of IOPs and SOPs in their operations to avoid excessive monetary spending. Ensuring GMP compliance in R&D activities is required to avoid product recalls, as it takes years to develop a product and product recalls may incur huge losses to the manufacturers. Moreover, by opting for GMP testing services in R&D, companies can carry out proper research activities and develop products according to the needs of the GMP testing services. Thus, the growing adoption of GMPs in R&D activities is expected to create notable opportunities for the growth of the Europe GMP testing service market during the forecast period. This is expected to drive the Europe GMP testing service market during the forecast period.
On the contrary, absence of uniform regulatory framework related to GMP testing services hurdles the growth of Europe GMP testing service market.
Based on service type, the Europe GMP testing service market is categorized into product validation testing, bioanalytical services, packaging & shelf-life testing, and other services type. The product validation testing segment held 37.3% share of the Europe GMP testing service market in 2022, amassing US$ 230.29 million. It is projected to garner US$ 344.61 million by 2028 to expand at 6.9% CAGR during 2022–2028.
Based on end user, the Europe GMP testing service market is bifurcated into pharmaceutical and biopharmaceutical companies and medical device companies. The pharmaceutical and biopharmaceutical companies segment held 77.1% market share in 2022, amassing US$ 475.25 million. It is projected to garner US$ 475.25 million by 2028 to expand at 6.6% CAGR during 2022–2028.
Based on country, the Europe GMP testing service market has been categorized into the UK, Germany, France, Spain, Italy, and Rest of Europe. Our regional analysis states that Rest of Europe captured 38.9% share of the Europe GMP testing service market in 2022. It was assessed at US$ 240.13 million in 2022 and is likely to hit US$ 348.31 million by 2028, exhibiting a CAGR of 6.4% during the forecast period.
Key players dominating the Europe GMP testing service market are Eurofins Scientific; Almac Group; INTERTEK GROUP PLC; WuXi AppTec; Sartorius AG; North American Science Associates, Inc.; Nelson Laboratories, LLC.; and Thermo Fisher Scientific Inc. (PPD Inc.) among others.
- In May 2019, Altasciences and WuXi AppTec Entered into Collaboration for WIND Projects.
- In Dec 2021, Sartorius acquired a majority stake in ALS Automated Lab Solutions and strengthens its bioanalytics portfolio.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com